Clinical Trials Browser

Esophageal Neoplasms

NCT07223424 2026-04-16

PSI-Immune

DermatologicGastrointestinalGenitourinaryGynecologicThoracic

Adenocarcinoma Of Esophagus, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Colitis, Ulcerative, Colonic Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Melanoma

NCT07533357 2026-04-16

Tpex Subsets in Negative Tumor Draining Lymph Nodes for Predicting the Efficacy of PD 1 Inhibitors in Advanced or Recurrent Esophageal Squamous Cell Carcinoma

Not yet recruiting

158 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT01512589 2026-04-15

Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) Trial

Phase 2 Active not recruiting

147 enrolled

Gastrointestinal

Adenocarcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT03161522 2026-04-15

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

Phase 2 Recruiting

100 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT03948100 2026-04-15

Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers

Phase NA Recruiting

400 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Lung Neoplasms

NCT07312526 2026-04-15

Shanghai Clinical Cohort - Esophageal Cancer

Completed

2,116 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT07519486 2026-04-15

INS-ESCC-CT

Phase 2 Recruiting

118 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT07530094 2026-04-15

STELLAR01

Phase 2 Recruiting

98 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT07530549 2026-04-15

A Phase II Single-arm Clinical Study in the Treatment of Locally Advanced Esophageal Cancer After Failed Neoadjuvant Chemoimmunotherapy

Phase 2 Not yet recruiting

40 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT00260559 2026-04-14

Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life

Recruiting

3,500 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT00260585 2026-04-14

Esophageal Cancer Risk Registry

Recruiting

7,000 enrolled

Gastrointestinal

Esophageal Achalasia, Esophageal Diseases, Esophageal Neoplasms, Gastroesophageal Reflux, Hernia, Hiatal

NCT06960889 2026-04-14

A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients

Active not recruiting

500 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT03102229 2026-04-13

RAMPART

Phase NA Completed

40 enrolled

GastrointestinalHead & NeckThoracic

Esophageal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Stomach Neoplasms

NCT05450484 2026-04-13

OPTIC

Phase 1 Completed

21 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT07518680 2026-04-08

A Clinical Study on the Effect of Massaging Tian Tu Acupoint on Coughing After Esophageal Surgery

Phase NA Not yet recruiting

30 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT03764553 2026-04-07

LyRICX

Phase 2 Active not recruiting

320 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT05334069 2026-04-07

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Recruiting

2,000 enrolled

BreastDermatologicGastrointestinalGenitourinaryHead & NeckLymphoidMyeloidOther hematologic neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Esophageal Neoplasms, Lung Neoplasms, Melanoma, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07283939 2026-04-07

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Phase NA Recruiting

420 enrolled

Gastrointestinal

Appendiceal Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT00213486 2026-04-06

Weekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II Trial

Phase 2 Completed

43 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT04908111 2026-04-06

A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1

Phase 1/2 Suspended

15 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Lung Neoplasms, Neoplasms, Neoplasms, Squamous Cell

NCT06275737 2026-04-06

POP-UP

Phase NA Active not recruiting

9 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT03482791 2026-04-02

Proton Beam Therapy in the Treatment of Esophageal Cancer

Phase NA Active not recruiting

22 enrolled 29 charts

Gastrointestinal

Esophageal Neoplasms

NCT05480384 2026-04-01

Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction

Phase 2 Active not recruiting

1 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT07187154 2026-04-01

The Application of Symptoms Management Program Based on the Patient Reported Outcome After Esophagectomy

Phase NA Not yet recruiting

252 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT02530983 2026-03-30

UDD

Recruiting

1,000 enrolled

Gastrointestinal

Digestive System Abnormalities, Esophageal Neoplasms

NCT05145647 2026-03-27

To Observe the Benefit of Adding Brachytherapy After CCRT on Resectable Esophageal Cancer Patients Without Surgery

Phase NA Active not recruiting

18 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT06447064 2026-03-25

(CLOCS-2)

Recruiting

2,900 enrolled

GastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT06476678 2026-03-25

Novel Bipolar Radiofrequency Ablation Knife in Esophageal Lesions

Recruiting

50 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT07063901 2026-03-24

Multimodal Deep Learning for Predicting Treatment Response to Neoadjuvant Chemoimmunotherapy in Esophageal Cancer

Recruiting

200 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT03044613 2026-03-23

Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer

Phase 1 Active not recruiting

32 enrolled

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

NCT06792786 2026-03-23

A Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring

Phase NA Recruiting

30 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT05143970 2026-03-20

CHANCES

Phase 1 Recruiting

27 enrolled

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT06343597 2026-03-20

Volume Outcome Relationships and Effects

Recruiting

30 enrolled

Gastrointestinal

Esophageal Neoplasms

Clinical Trials

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

PSI-Immune

Tpex Subsets in Negative Tumor Draining Lymph Nodes for Predicting the Efficacy of PD 1 Inhibitors in Advanced or Recurrent Esophageal Squamous Cell Carcinoma

Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) Trial

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers

Shanghai Clinical Cohort - Esophageal Cancer

INS-ESCC-CT

STELLAR01

A Phase II Single-arm Clinical Study in the Treatment of Locally Advanced Esophageal Cancer After Failed Neoadjuvant Chemoimmunotherapy

Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life

Esophageal Cancer Risk Registry

A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients

RAMPART

OPTIC

A Clinical Study on the Effect of Massaging Tian Tu Acupoint on Coughing After Esophageal Surgery

LyRICX

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Weekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II Trial

A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1

POP-UP

Proton Beam Therapy in the Treatment of Esophageal Cancer

Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction

The Application of Symptoms Management Program Based on the Patient Reported Outcome After Esophagectomy

UDD

To Observe the Benefit of Adding Brachytherapy After CCRT on Resectable Esophageal Cancer Patients Without Surgery

(CLOCS-2)

Novel Bipolar Radiofrequency Ablation Knife in Esophageal Lesions

Multimodal Deep Learning for Predicting Treatment Response to Neoadjuvant Chemoimmunotherapy in Esophageal Cancer

Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer

A Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring

CHANCES

Volume Outcome Relationships and Effects